The Asia Pacific Vitamin K2 Market would witness market growth of 13.8% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $29.35 millions by 2031. The Japan market is registering a CAGR of 13% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 14.5% during (2024 - 2031).
The vitamin K2 market is experiencing significant growth, fueled by an increasing awareness of its critical role in human health. Vitamin K2, a fat-soluble vitamin, has garnered attention for its unique benefits, particularly in bone and cardiovascular health.
Additionally, Vitamin K2, in contrast to the more well-known vitamin K1, which is primarily engaged in the process of blood clotting, plays a significant role in the metabolism of calcium. It ensures that calcium is adequately delivered to the bones and teeth while also preventing calcium from reaching the arteries and soft tissues.
Public awareness regarding the health benefits of vitamin K2, especially for bone health and heart function, is on the rise across the Asia Pacific. This increased knowledge drives consumer interest in incorporating vitamin K2 supplements into their routines. Japan, in particular, has a historical connection with vitamin K2 through the traditional consumption of natto, a fermented soybean product rich in MK-7. This cultural practice has helped drive the awareness and acceptance of vitamin K2's health benefits in the broader population.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $29.35 millions by 2031. The Japan market is registering a CAGR of 13% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 14.5% during (2024 - 2031).
The vitamin K2 market is experiencing significant growth, fueled by an increasing awareness of its critical role in human health. Vitamin K2, a fat-soluble vitamin, has garnered attention for its unique benefits, particularly in bone and cardiovascular health.
Additionally, Vitamin K2, in contrast to the more well-known vitamin K1, which is primarily engaged in the process of blood clotting, plays a significant role in the metabolism of calcium. It ensures that calcium is adequately delivered to the bones and teeth while also preventing calcium from reaching the arteries and soft tissues.
Public awareness regarding the health benefits of vitamin K2, especially for bone health and heart function, is on the rise across the Asia Pacific. This increased knowledge drives consumer interest in incorporating vitamin K2 supplements into their routines. Japan, in particular, has a historical connection with vitamin K2 through the traditional consumption of natto, a fermented soybean product rich in MK-7. This cultural practice has helped drive the awareness and acceptance of vitamin K2's health benefits in the broader population.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc.
Market Report Segmentation
By Product Type- MK-7
- MK-4
- Powder & Crystalline
- Capsules & Tablets
- Oils & Liquid
- Health Supplements
- Pharmaceutical
- Functional Food & Beverages
- Natural
- Synthetic
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Vitamin K2 Market by Product Type
Chapter 5. Asia Pacific Vitamin K2 Market by Form
Chapter 6. Asia Pacific Vitamin K2 Market by Application
Chapter 7. Asia Pacific Vitamin K2 Market by Source
Chapter 8. Asia Pacific Vitamin K2 Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc.
Methodology
LOADING...
